NEW YORK, NY, USA I April 01, 2025 I Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...

The Malinauskas Labor Government is keeping South Australian babies safe from Respiratory Syncytial Virus (RSV) this winter, with a long-acting ...

My question relates to a situation where a person gets a vaccine for, say, flu, COVID or shingles and is later exposed to the virus. Is it possible ...

The Royal Australian College of GPs (RACGP) has thrown its support behind South Australia's infant RSV immunisation program. Respiratory syncytial ...

Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...

Measles is spreading fast across the U.S., putting infants at risk. Should babies get vaccinated before age 1? Here's what ...

Vermont has the second lowest state fatality rate in the US (146.4 per 100K; Hawaii 112.8/100K). Mississippi (463.3/100K) and ...

COVID, flu and RSV levels have already hit their peaks. (Pollen levels and springtime allergies are a whole different story.) ...

Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

Pfizer has won European Commission expanded approval of its Abrysvo vaccine for respiratory syncytial virus, or RSV, for use in all adults. The New York drugmaker on Tuesday said the extended ...